Federal contract award
W81XWH22C0118
AWARD OF NANOMATRONIX'S DHA SBIR SEQUENTIAL PHASE II MEDICAL R&D CONTRACT FOR "THE AMBIT PLATFORM: AN IN VITRO SYSTEM FOR TRAUMATIC BRAIN INJURY R&D", PROPOSAL NO. H2-0710.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.1M |
| Current contract value | $1.1M |
| Potential contract value / ceiling | $1.1M |
| Start date | Sep 22, 2022 |
| Current end date | Jun 30, 2025 |
| Potential end date | Jun 30, 2025 |
| Latest award activity | Apr 17, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 17, 2025 | P00002 | $0 | DEFENSE HEALTH AGENCY SMALL BUSINESS TECHNOLOGY TRANSFER SEQUENTIAL PHASE II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR PROJECT TITLED: THE AMBIT PLATFORM: AN IN VITRO SYSTEM FOR TRAUMATIC BRAIN INJURY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.